table of content
1 Introduction to Research & Analysis Reports
1.1 Chimeric Antigen Receptor T Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chimeric Antigen Receptor T Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chimeric Antigen Receptor T Cell Therapy Overall Market Size
2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Size: 2022 VS 2029
2.2 Global Chimeric Antigen Receptor T Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chimeric Antigen Receptor T Cell Therapy Players in Global Market
3.2 Top Global Chimeric Antigen Receptor T Cell Therapy Companies Ranked by Revenue
3.3 Global Chimeric Antigen Receptor T Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Chimeric Antigen Receptor T Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chimeric Antigen Receptor T Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chimeric Antigen Receptor T Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Chimeric Antigen Receptor T Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor T Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chimeric Antigen Receptor T Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 Allogeneic
4.1.3 Autologous
4.2 By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chimeric Antigen Receptor T Cell Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Universities and Colleges
5.1.4 Others
5.2 By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Chimeric Antigen Receptor T Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.3.2 US Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.3.3 Canada Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.3.4 Mexico Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.4.2 Germany Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.3 France Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.4 U.K. Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.5 Italy Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.6 Russia Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.4.8 Benelux Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.5.2 China Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5.3 Japan Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5.4 South Korea Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.5.6 India Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.6.2 Brazil Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.6.3 Argentina Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029
6.7.2 Turkey Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.7.3 Israel Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
6.7.5 UAE Chimeric Antigen Receptor T Cell Therapy Market Size, 2018-2029
7 Chimeric Antigen Receptor T Cell Therapy Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.1.4 Amgen Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Bellicum Pharmaceuticals
7.2.1 Bellicum Pharmaceuticals Company Summary
7.2.2 Bellicum Pharmaceuticals Business Overview
7.2.3 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.2.4 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Bellicum Pharmaceuticals Key News & Latest Developments
7.3 Bluebird Bio
7.3.1 Bluebird Bio Company Summary
7.3.2 Bluebird Bio Business Overview
7.3.3 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.3.4 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Bluebird Bio Key News & Latest Developments
7.4 Caribou Biosciences
7.4.1 Caribou Biosciences Company Summary
7.4.2 Caribou Biosciences Business Overview
7.4.3 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.4.4 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Caribou Biosciences Key News & Latest Developments
7.5 Celgene Corporation
7.5.1 Celgene Corporation Company Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.5.4 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Celgene Corporation Key News & Latest Developments
7.6 Cellectis
7.6.1 Cellectis Company Summary
7.6.2 Cellectis Business Overview
7.6.3 Cellectis Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.6.4 Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Cellectis Key News & Latest Developments
7.7 Celyad Oncology
7.7.1 Celyad Oncology Company Summary
7.7.2 Celyad Oncology Business Overview
7.7.3 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.7.4 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Celyad Oncology Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.8.4 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
7.9 Intellia Therapeutics
7.9.1 Intellia Therapeutics Company Summary
7.9.2 Intellia Therapeutics Business Overview
7.9.3 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.9.4 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Intellia Therapeutics Key News & Latest Developments
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.10.4 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Johnson & Johnson Key News & Latest Developments
7.11 Legend Biotech
7.11.1 Legend Biotech Company Summary
7.11.2 Legend Biotech Business Overview
7.11.3 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.11.4 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Legend Biotech Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.12.4 Merck Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Merck Key News & Latest Developments
7.13 Noile-Immune Biotech
7.13.1 Noile-Immune Biotech Company Summary
7.13.2 Noile-Immune Biotech Business Overview
7.13.3 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.13.4 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 Noile-Immune Biotech Key News & Latest Developments
7.14 Novartis
7.14.1 Novartis Company Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.14.4 Novartis Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.14.5 Novartis Key News & Latest Developments
7.15 Pfizer
7.15.1 Pfizer Company Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.15.4 Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.15.5 Pfizer Key News & Latest Developments
7.16 Sangamo Therapeutics
7.16.1 Sangamo Therapeutics Company Summary
7.16.2 Sangamo Therapeutics Business Overview
7.16.3 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.16.4 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.16.5 Sangamo Therapeutics Key News & Latest Developments
7.17 Servier Laboratories
7.17.1 Servier Laboratories Company Summary
7.17.2 Servier Laboratories Business Overview
7.17.3 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Major Product Offerings
7.17.4 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue in Global Market (2018-2023)
7.17.5 Servier Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
